383 related articles for article (PubMed ID: 14996438)
1. A haplotype constituted of four MMP-2 promoter polymorphisms (-1575G/A, -1306C/T, -790T/G and -735C/T) is associated with coronary triple-vessel disease.
Vasků A; Goldbergová M; Izakovicová Hollá L; Sisková L; Groch L; Beránek M; Tschöplová S; Znojil V; Vácha J
Matrix Biol; 2004 Jan; 22(7):585-91. PubMed ID: 14996438
[TBL] [Abstract][Full Text] [Related]
2. Matrix metalloproteinase-2 promoter variability in psoriasis.
Vasku V; Bienertova Vasku J; Slonková V; Kanková K; Vasku A
Arch Dermatol Res; 2009 Jul; 301(6):467-73. PubMed ID: 19360430
[TBL] [Abstract][Full Text] [Related]
3. [Polymorphism of gene promotor region for MMP-2 in rheumatoid arthritis].
Nemec P; Goldbergová M; Swobodnik T; Polásková D; Soucek M; Vasků A
Vnitr Lek; 2006 Apr; 52(4):348-54. PubMed ID: 16755991
[TBL] [Abstract][Full Text] [Related]
4. Functional haplotypes in the promoter of matrix metalloproteinase-2 predict risk of the occurrence and metastasis of esophageal cancer.
Yu C; Zhou Y; Miao X; Xiong P; Tan W; Lin D
Cancer Res; 2004 Oct; 64(20):7622-8. PubMed ID: 15492291
[TBL] [Abstract][Full Text] [Related]
5. [Study on the association of SNPs of MMP-2 and TIMP-2 genes with the risk of endometriosis and adenomyosis].
Zhao XW; Li Y; Wang N; Zhao J; Li XL; Liu Q; Jia JH; Yang ZF; Kang S
Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2008 Jun; 25(3):280-3. PubMed ID: 18543216
[TBL] [Abstract][Full Text] [Related]
6. Influence of MMP-2 and MMP-9 promoter polymorphisms on gene expression and clinical outcome of non-small cell lung cancer.
Rollin J; Régina S; Vourc'h P; Iochmann S; Bléchet C; Reverdiau P; Gruel Y
Lung Cancer; 2007 May; 56(2):273-80. PubMed ID: 17208328
[TBL] [Abstract][Full Text] [Related]
7. Association of interindividual differences in p14ARF promoter methylation with single nucleotide polymorphism in primary colorectal cancer.
Kang MY; Lee BB; Ji YI; Jung EH; Chun HK; Song SY; Park SE; Park J; Kim DH
Cancer; 2008 Apr; 112(8):1699-707. PubMed ID: 18327804
[TBL] [Abstract][Full Text] [Related]
8. Association of a haplotype of matrix metalloproteinase (MMP)-1 and MMP-3 polymorphisms with renal cell carcinoma.
Hirata H; Okayama N; Naito K; Inoue R; Yoshihiro S; Matsuyama H; Suehiro Y; Hamanaka Y; Hinoda Y
Carcinogenesis; 2004 Dec; 25(12):2379-84. PubMed ID: 15319295
[TBL] [Abstract][Full Text] [Related]
9. Genetic polymorphisms in the MMP-1 and MMP-3 gene may contribute to chronic periodontitis in a Brazilian population.
Astolfi CM; Shinohara AL; da Silva RA; Santos MC; Line SR; de Souza AP
J Clin Periodontol; 2006 Oct; 33(10):699-703. PubMed ID: 16899023
[TBL] [Abstract][Full Text] [Related]
10. [Correlations of polymorphisms in matrix metalloproteinase-3 and -7 promoters to susceptibility to brain astrocytoma].
Lu ZQ; Wang YM; Cao YY; Zhang QJ; Zhang XH; Li YH; Wang HS; Xie HL; Jiao BH; Zhang JH
Ai Zheng; 2007 May; 26(5):463-8. PubMed ID: 17672933
[TBL] [Abstract][Full Text] [Related]
11. Matrix metalloproteinase-2 promoter and tissue inhibitor of metalloproteinase-2 gene polymorphisms in non-Hodgkin's lymphoma.
Diao LP; Ma H; Wei GC; Li T; Liu HS; Liu LH; Wu LL; Zhao GM; Gao YH
Int J Cancer; 2012 Sep; 131(5):1095-103. PubMed ID: 22020421
[TBL] [Abstract][Full Text] [Related]
12. Analysis of MMP2 promoter polymorphisms in patients with pseudoxanthoma elasticum.
Zarbock R; Hendig D; Szliska C; Kleesiek K; Götting C
Clin Chim Acta; 2010 Oct; 411(19-20):1487-90. PubMed ID: 20541540
[TBL] [Abstract][Full Text] [Related]
13. Matrix metalloproteinase 1 promoter polymorphisms and risk of myocardial infarction: a case-control study in a Spanish population.
Román-García P; Coto E; Reguero JR; Cannata-Andía JB; Lozano I; Avanzas P; Morís C; Rodríguez I
Coron Artery Dis; 2009 Sep; 20(6):383-6. PubMed ID: 19620856
[TBL] [Abstract][Full Text] [Related]
14. Genetic analysis of MMP gene polymorphisms in patients with Kawasaki disease.
Ikeda K; Ihara K; Yamaguchi K; Muneuchi J; Ohno T; Mizuno Y; Hara T
Pediatr Res; 2008 Feb; 63(2):182-5. PubMed ID: 18091353
[TBL] [Abstract][Full Text] [Related]
15. [Single nucleotide polymorphism in the matrix metalloproteinases promoter is associated with susceptibility to endometriosis and adenomyosis].
Kang S; Wang Y; Zhang JH; Jin X; Fang SM; Li Y
Zhonghua Fu Chan Ke Za Zhi; 2005 Sep; 40(9):601-4. PubMed ID: 16202315
[TBL] [Abstract][Full Text] [Related]
16. Polymorphisms in the promoter regions of the matrix metalloproteinases-1, -3, -7, and -9 and the risk of epithelial ovarian cancer in China.
Li Y; Jin X; Kang S; Wang Y; Du H; Zhang J; Guo W; Wang N; Fang S
Gynecol Oncol; 2006 Apr; 101(1):92-6. PubMed ID: 16278009
[TBL] [Abstract][Full Text] [Related]
17. Functional haplotypes in the promoter of matrix metalloproteinase-2 and lung cancer susceptibility.
Zhou Y; Yu C; Miao X; Wang Y; Tan W; Sun T; Zhang X; Xiong P; Lin D
Carcinogenesis; 2005 Jun; 26(6):1117-21. PubMed ID: 15731163
[TBL] [Abstract][Full Text] [Related]
18. Two MMP-2 promoter polymorphisms (-790T/G and -735C/T) in chronic heart failure.
Vasků A; Goldbergová M; Hollá LI; Spinarová L; Spinar J; Vítovec J; Vácha J
Clin Chem Lab Med; 2003 Oct; 41(10):1299-303. PubMed ID: 14580155
[TBL] [Abstract][Full Text] [Related]
19. Genetic variations in the human gelatinase A (matrix metalloproteinase-2) promoter are not associated with susceptibility to, and severity of, chronic periodontitis.
Holla LI; Fassmann A; Vasku A; Goldbergova M; Beranek M; Znojil V; Vanek J; Vacha J
J Periodontol; 2005 Jul; 76(7):1056-60. PubMed ID: 16018746
[TBL] [Abstract][Full Text] [Related]
20. Haplotype effect of the matrix metalloproteinase-1 gene on risk of myocardial infarction.
Pearce E; Tregouet DA; Samnegård A; Morgan AR; Cox C; Hamsten A; Eriksson P; Ye S
Circ Res; 2005 Nov; 97(10):1070-6. PubMed ID: 16210545
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
